|International Guidelines for Active Standing Test Procedure|
|New indicators to be added to the NICE indicator menu for general practice - August 2017|
|New indicators to be added to the NICE indicator menu for
clinical commissioning groups -August 2017
|Dual-chamber pacemakers for symptomatic bradycardia due to sick sinus syndrome without atrioventricular block (part review of technology appraisal guidance 88) 2014|
Many people are familiar with the National Institute for Health and Care Excellence (NICE) from the media, usually in the context of the availability of new medicines. By understanding how NICE works patients and relatives can see what role they can play within its processes. This helps ensure that NICE makes appropriate decisions about recommending new therapies.
NICE is responsible for providing national guidance and advice on promoting high quality health, public health and social care. It is an independent organisation that produces a range of evidence-based guidance, information and advice for health, public health and social care services. It was set up in 1999 to evaluate medications, treatments and procedures and decides whether they should be available on the NHS in England and Wales. It is important to remember that Scotland and Northern Ireland have separate organisations which make these decisions.
One key aim of NICE is to determine which medications, treatments and procedures are clinically effective and cost effective and to ensure people have equal access to them, regardless of where they live. This process was intended to do away with the ‘postcode lottery’, which denied drugs or treatments to patients on the basis of
where they lived.
Being a NICE patient expert
NICE (National Institute for Health and Care Excellence) seeks evidence from patient experts during the appraisal of a medicine or technology in order to provide as full an assessment of its clinical and cost eff ectiveness as possible. Patient experts are either patients themselves who may or may not have experience of the treatment, or representatives of a wider patient community who have an interest in the appraisal.
|2018 ESC Guidelines for the diagnosis and management of syncope|
|Guidelines for the diagnosis and management of syncope (version 2009)|
|2003 ACC/AHA/ESC Guidelines for the Management of Patients
With Supraventricular Arrhythmias
|Guideline for the Evaluation and Management of Patients With Syncope 2017|
Guideline for the Evaluation and Management of Patients With Syncope
Syncope, or fainting, is caused by low blood pressure resulting in an insufficient supply of blood, and therefore oxygen, to the brain. This can happen due to several causes, some of them even due to a serious underlying medical condition. Until now, there have been no written standards outlining the best course of action to take when treating patients who faint.
The Government’s mandate to NHS England for 2017-18
The NHS has a unique place at the heart of our society and is – by some distance – the institution that makes us most proud to be British.
It is because of this that the 2017-18 mandate to NHS England goes further than ever before to ensure that we not only deliver the best care and support to today’s NHS patients, but also deliver the reform and renewal needed to sustain the NHS for the future.